The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis
- Resource Type
- Article
- Source
- In
Atherosclerosis June 2016 249:200-208 - Subject
- Language
- ISSN
- 0021-9150